VIB VZW;Universite de Montpellier;Universiteit Gent;Centre National de la Recherche Scientifique
发明人:
Jan TAVERNIER,Jose VAN DER HEYDEN,Genevieve GARCIN,Gilles UZE,Yann BORDAT
申请号：
US16475305
公开号：
US20190351021A1
申请日:
2018.02.06
申请国别(地区):
US
年份:
2019
代理人:
摘要：
The present invention relates, in part, to targeted chimeric proteins with beneficial therapeutic effects, including, for example, effects mediated by chimeric proteins which comprise modified signaling agents two or more targeting moieties. Methods of treatment and pharmaceutical compositions comprising the chimeric proteins are also provided. The present invention finds use in the treatment of various disease and disorders.
